3Valentjjn RM, van Overhagen H, Hager-Oct HM, et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus[J] . Arthritis Rheum, 1985,28:904.
4Bell DA, Morrison B, van den Bygaart P. Immunogenic DNA-related factors, nucleosomes spontaneously released from normal murine lymphoid cells "stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes[J]. J Clin Invest, 1990,85:1487.
5Stennicke HR, Salvesen GS. Properties of the caspase[J] . Biochim Biophys Acta, 1998, 1387:17.
6Tax WJ, Kramers C, van Bruggen MC, et al. Apoptosis, nucleosomes,and nephritis in systemic lupus erythmatosus[J]. Kidney lnt, 1995,48:666.
7Emlen W,Niebur J, Fadera R. Accelerated in vitro apoptosis of lymphocyte from patients with systemic lupus erythematosus[J]. J Immunol, 1994, 152 : 3685.
8Mountz JD,Wu J, Cheng J, et al. Autoimmune disease: a problem of defective apoptosis[J]. Arthritis Rheum, 1994,34:1415.
6Araki S,Haneda M,Koya D,et al.Predictive impact of elevated serum levels of IL-18for early renal dysfunction in type2diabetes:an observational follow-up study[J].Diabetologia,2007,50(4):867-873.
7Nakamura A,Shikata K,Hiramatsu M,et al.Serum interleukin-18levels are associated with nephropathy and atherosclero-sis Japanese patients with type2diabetes[J].Diabetes Care,2005,28(12):2890-2895.
8Miyauchi K,Takiyama Y,Honjyo J.Upregulated IL-18ex-pression in type2diabetic subjects with nephropathy[J].Diabetes ReS Clin Pract,2009,83(2):190-199.
9Navarro-Gonzalez JF,Mora-Fernandez C.The role of in-flammatory cytokines in diabetic nephropathy[J].J Am Soc Nephrol,2008,19(3):433-442.
10Dinarello CA.Interleukin-18and the pathogenesis of in-flammatory diseases[J].Semin Nephrol,2007,27(1):98-114.
